Oxidative stress and diabetic neuropathy: Pathophysiological mechanisms and treatment perspectives

Diabetes/Metabolism Research and Reviews

Volumn 18, Issue 3, 2002, Pages 176-184

  Sytze Van Dam, P ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Antioxidants; Diabetic neuropathy; Nerve blood flow; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BM 150639; DEFEROXAMINE; ENZYME INHIBITOR; GAMMA LINOLENIC ACID; IDITOL DEHYDROGENASE INHIBITOR; INSULIN; NITRIC OXIDE SYNTHASE INHIBITOR; PLACEBO; PROBUCOL; PROTEIN KINASE C INHIBITOR; TAURINE; THIOCTIC ACID; TRIENTINE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; BLOOD FLOW; CLINICAL STUDY; CONTROLLED STUDY; DIABETIC NEUROPATHY; HUMAN; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; NERVE CONDUCTION; NONHUMAN; NUTRITION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; REVIEW; ANIMAL; CELL CULTURE; DISEASE MODEL; PHYSIOLOGY;

ANIMAL; ANTIOXIDANTS; CELLS, CULTURED; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; HUMAN; OXIDATIVE STRESS; ANIMALS; HUMANS;

EID: 0035985234     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.287     Document Type: Review

References (78)

1. Diabetic neuropathy: Pathogenesis and therapy
2. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy
3. Pathology and pathogenetic mechanisms of diabetic neuropathy
4. Diabetic neuropathy - A continuing enigma
5. Experimental diabetic neuropathy: An update
6. The role of oxidative stress in neuropathy and other diabetic complications
7. Oxidative stress and antioxidant treatment in diabetic neuropathy
8. Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy
9. Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications
10. Glycation (non-enzymic glycosylation) inactivates glutathione reductase
11. Increased glycated Cu,Zn-superoxide dismutase levels in erythrocytes of patients with insulin-dependent diabetes mellitus
12. Significance of fructose-induced protein oxidation and formation of advanced glycation end product
13. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm
14. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: A link between surface-associated AGEs complications
15. Nerve Na-K-ATPase conduction, and myo-inositol in the insulin-deficient BB rat
16. Relationship between glutathione and sorbitol concentrations in erythrocytes from diabetic patients
17. The effect of acute glutathione treatment on sorbitol level in erythrocytes from diabetic patients
18. Effect of aldose reductase inhibition on glutathione redox status in erythrocytes of diabetic patients
19. The increase in lipid peroxidation in diabetic rat lens can be reversed by oral sorbinil
20. Diabetes-induced changes in lens antioxidant status glucose utilization and energy metabolism: Effect of DL-alpha-lipoic acid
21. Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozocin-induced diabetic rats
22. Comparison of the effects of inhibitors of eldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats
23. Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: A prevention study
24. Restoration of Na (+)-K+ pump activity and resting membrane potential by myo-inositol supplementation in neuroblastoma cells chronically exposed to glucose or galactose
25. Measurement of Na(+)-K+ pump current in isolated rabbit ventricular myocytes using the whole-cell voltage-clamp technique. Inhibition of the pump by oxidant stress
26. Lipid peroxidation as the mechanism of modification of the affinity of the Na+, K+-ATPase active sites for ATP, K+, Na+, and strophanthidin in vitro
27. Different sentivities of the Na+/K(+)-ATPase isoforms to oxidants
28. Effect of high glucose levels on Na+ K+-ATPase and lipid peroxidation in cultured dorsal root ganglion cells
29. Alpha-lipoic acid: Antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathy
30. Antioxidant protection mechanisms and arachidonic acid synthesis are altered in Schwann cells grown in elevated glucose
31. Taurine replacement prevents apotosis in experimental diabetic neuropathy
32. Neurons undergo apoptosis in animal and cell culture models of diabetes
33. Antioxidant and glutathione-related enzymatic activities in rat sciatic nerve
34. Oxgen toxicity in the nervous tissue: Comparison of the antioxidant defense of rat brain and sciatic nerve
35. Antioxidants in peripheral nerve
36. Oxygen free radical effects in sciatic nerve in experimental diabetes
37. Effect of aplha-tocopherol deficiency on indices of oxidative stress in normal and diabetic peripheral nerve
38. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy
39. Protein kinase C effects on nerve function, perfusion, NA(+), K(+)-ATPase activity and glutathione content in diabetic rats
40. Decreased glutathione peroxidase activity in sciatic nerve of alloxan-induced diabetic mice and its correlation with blood glucose levels
41. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat
42. Effects of DL-α-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy
43. Effects of insulin treatment on endoneurial and systemic oxidative stress in relation to nerve conduction in streptozocin -diabetic rats
44. Nerve function and oxidative stress in diabetic and vitamin E-deficient rats
45. Glutathione and α-lipoate in diabetic rats: Nerve function, blood flow and oxidative state
46. Nerve conduction and antioxidant levels in experimentally diabetic rats: Effects of streptozotocin dose and diabetes duration
47. Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals
48. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats
49. Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats
50. Potential use of gluthione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat
51. Effects of the sulphydryl donor N-acetyl-L-cysteine on nerve conduction, perfusion, maturation and regeneration following freeze damage in diabetic rats
52. Neurovascular dysfunction in diabetic rats - Potential contribution of autoxidation and free radicals examined using transition metal chelating agents
53. Effects of natural free radical scavengers on peripheral nerve and neurovascualr function in diabetic rats
54. Nerve function and regeneration in diabetic and galactosaemic rats: Antioxidant and metal chelator effects
55. Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcystein
56. Effects of anti-oxidant treatment on sciatic nerve dysfunction in strepto-zotocin-diabetic rats; comparison with essential fatty acids
57. Depletion of taurine in experimental diabetic neuropathy: Implications for nerve metabolic, vascular, and functional deficits
58. Reversal of peripheral nerve conduction and perfusion deficits by the free radical scavenger, BM15.0639, in diabetic rats
59. Interaction between oxidative stress and gamma-linolenic acid in impaired neurovascular function of diabetic rats
60. Effects of alpha-tocopherol on nerve conduction velocity and regeneration following a freeze lesion in immature diabetic rats
61. High rat food vitamin E content improves nerve function in streptozotocin-diabetic rats
62. Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy
63. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy
64. Effects of alpha-lipoic acid on neurovascular function in diabetic rats: Interaction with essential fatty acids
65. Alphalipoic acid corrects neuropeptide deficits in diabetic rats via induction of trophic support
66. A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy
67. The effect of gamma-linolenic acid-alpha-lipoic acid on functional deficits in the peripheral and central nervous system of streptozotocin- diabetic rats
68. α-Lipoic acid: Effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy
69. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
70. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid - A 3-week multicentre randomized controlled trial (ALADIN Study)
71. Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy
72. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: A 7-month multicenter randomized controlled trial (ALADIN III Study)
73. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): A two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy
74. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients: A 4-month randomized controlled multicenter trial (DEKAN Study)
75. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: Current evidence from clinical trials
76. Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes - A preliminary study
77. Chronic administration of pharmacologic doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes